Eli Lilly makes modest bet on ‘all-in-human’ discovery outfit for ALS drugs, deepening bid in precision neurology

For years, Big Pharma has retreated from neurology amid a series of high-profile failures in the big-ticket indications such as Alzheimer’s and ALS. But the tide has turned in recent years, and big drugmakers like Eli Lilly have doubled down on their investments in the space.

Now, looking to crack...

Click to view original post